Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 19/20 | 0.47 |
| ▸ | EGLN3 | Q9H6Z9 | 4/20 | 0.44 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.44 |
| ▸ | VEGFA | P15692 | 2/20 | 0.42 |
| ▸ | FLT1 | P17948 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6567446 | 0.94 | EGLN1 (0.46) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL8779216 | 0.91 | EGLN1 (0.49) | EGLN1EGLN3FTOVEGFAFLT1 | |
| Hydrochloric Acid SCHEMBL6565656 | 0.90 | EGLN1 (0.48) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL8630490 | 0.88 | EGLN1 (0.43) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL8632215 | 0.88 | EGLN1 (0.46) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL6566160 | 0.85 | EGLN1 (0.47) | EGLN1EGLN3FTO | |
| SCHEMBL967780 | 0.84 | EGLN1 (0.48) | EGLN1EGLN3FTO | |
| SCHEMBL6566125 | 0.83 | EGLN1 (0.52) | EGLN1EGLN3FTOVEGFAFLT1 | |
| SCHEMBL6564074 | 0.83 | EGLN1 (0.45) | EGLN1EGLN3FTO | |
| SCHEMBL8627737 | 0.82 | EGLN1 (0.45) | EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0765871-B1 | Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors | FIBROGEN INC (US) | 2004-03-31 | — | — | EP | disclosed |
| US-5726305-A | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-03-10 | — | — | US | disclosed |
| US-5719164-A | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-02-17 | — | — | US | disclosed |
| US-5620995-A | Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-04-15 | — | — | US | disclosed |
| EP-0765871-A1 | Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-04-02 | — | — | EP | disclosed |
| EP-0661269-B1 | Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments | HOECHST AG (DE) | 1997-03-26 | — | — | EP | disclosed |
| EP-0661269-A1 | Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-07-05 | — | — | EP | disclosed |